New FY 2022 Categorical Spending Data Are Now Available
NIH recently updated its annual categorical information with fiscal year (FY) 2022 actual spending data and estimates for FY 2023 and 2024. Available on the Research, Condition, and Disease Categorization (RCDC) page, you will find the annual support level for various research, condition, and disease categories. The data are based on grants, contracts, and other funding mechanisms used across NIH. There were 215 public categories when RCDC information began being reported in 2008. Now in our fifteenth year, there are a total of 315 categories. The following new categories were added in FY 2022: Cocaine PASC (Post-Acute Se...
Source: NIH Extramural Nexus - April 4, 2023 Category: Research Authors: NIH Staff Tags: New Resources NIH budget RCDC Source Type: funding

HEAL Initiative: Team Research for Initial Translational Efforts in Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] (U19 Clinical Trial Not Allowed)
Funding Opportunity RFA-NS-22-052 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) is part of a suite of FOAs to support the development of safe, effective, and non-addictive therapeutics to treat pain. The goal of this FOA is to support team-based research projects to develop assays, screening and early optimization work to develop a non-addictive therapeutic to treat pain. Discovery and validation of pharmacodynamic markers efficacy and pharmacokinetic/pharmacodynamic (PK/PD) studies are also responsive. The result of the project should be to advance a hit or lead to the point w...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 22, 2022 Category: Research Source Type: funding

Notice of Special Interest (NOSI) in Migraine and Headache Research
Notice NOT-NS-22-051 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 27, 2021 Category: Research Source Type: funding

HEAL Initiative: Analgesic Development Initial Translational Efforts [Small Molecules and Biologics] (U19 Clinical Trial Not Allowed)
Funding Opportunity RFA-NS-21-015 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) is part of a suite of FOAs to support the development of safe, effective, and non-addictive therapeutics to treat pain. The goal of this FOA is to support team-based research projects to develop assays, screening and early optimization work to develop a non-addictive therapeutic to treat pain. Discovery and validation of pharmacodynamic markers efficacy and pharmacokinetic/pharmacodynamic (PK/PD) studies are also responsive. The result of the project should be to advance a hit or lead to the point w...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 11, 2021 Category: Research Source Type: funding

Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-NS-18-043 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to promote the discovery and validation of novel therapeutic targets to facilitate the development of pain therapeutics. Specifically, the focus of this FOA is on the basic science discovery of targets in the peripheral nervous system, central nervous system, immune system or other tissues in the body that can be used to develop treatments that have minimal side effects and little to no abuse/addiction liability. Research supported by this FOA must include rigorous validation studi...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 19, 2018 Category: Research Source Type: funding

Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed)
The purpose of this Funding Opportunity Announcement (FOA) is to promote the discovery and validation of novel therapeutic targets to facilitate the development of pain therapeutics. Specifically, the focus of this FOA is on the basic science discovery of targets in the peripheral nervous system, central nervous system, immune system or other tissues in the body that can be used to develop treatments that have minimal side effects and little to no abuse/addiction liability. Research supported by this FOA must include rigorous validation studies to demonstrate the robustness of the target as a pain treatment target. This wi...
Source: NIDDK Funding Opportunities - September 19, 2018 Category: Endocrinology Source Type: funding

Notice to Extend the Expiration Date for PA-14-068 "Neurobiology of Migraine (R01)"
Notice NOT-NS-17-027 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 27, 2017 Category: Research Source Type: funding

Notice to Extend the Expiration Date for PA-14-069 "Neurobiology of Migraine (R21)"
Notice NOT-NS-17-026 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 25, 2017 Category: Research Source Type: funding

Association of Migraine Disorders Research Grant
The purpose of this RFP is to support novel and transformative evidence-based research into migraine-related disorders. A preference will be given to basic science projects. Specifically the purpose of this RFP is: 1. To understand the pathophysiology of the neural malfunction that is called migraine disease 2. To prove or disprove a common pathophysiology among the multiple symptoms and syndromes that claim a relationship to migraine 3. To improve our understanding of the natural history of migraine disease at various stages of life, such as the differences between episodic and persistent migraine s...
Source: ScanGrants feed - October 8, 2014 Category: Research Authors: Association of Migraine Disorders Source Type: funding

Association of Migraine Disorders Resident Research Award
The purpose of this grant is to stimulate original resident research in migraine-related head and neck disorder projects that are well-conceived and scientifically valid, with the potential to advance the understanding of migraine disease. ELIGIBILITY Any resident of an accredited training program is eligible to apply for the AMD's Resident Research Grant(s). There are no restrictions on country of residence. Applications submitted by ineligible PIs will NOT be reviewed by the CORE Study Section. CONDITIONS Proposed projects may be related to any area of migraine-related head and neck disorders. Pr...
Source: ScanGrants feed - October 8, 2014 Category: Research Authors: Association of Migraine Disorders Source Type: funding

Harold Wolff-John Graham Award: An Award for Headache/Facial Pain Research
Sponsored by the AAN and endowed by Endo Pharmaceuticals. This award recognizes individuals who have submitted research results in the field of headache and facial pain. It honors two famous headache researchers and clinicians, who made outstanding contributions to the field of research in headache and inpatient care. Presentation Recipient is expected to present a 10-minute lecture during a headache scientific session at the AAN 67th Annual Meeting. Recipient will receive: -- Certificate of recognition and $1,000 prize -- Complimenary registration for 67th Annual Meeting -- $100 per diem p...
Source: ScanGrants feed - August 13, 2014 Category: Research Authors: American Academy of Neurology Source Type: funding

Request for Proposals: Migraine Research Foundation
GRANT AWARD: A maximum of $50,000 will be awarded to each grantee.   GRANT DURATION:  The expected project duration is one year. APPLICATION DEADLINE:  August 1, 2014. FUNDING RESTRICTIONS:  All grants must be used exclusively for research and research equipment, not capital expenditures, administrative costs, institutional overhead, publication costs or travel costs. FORMAT:  In addition to the Grant Application itself, grant requests must also include (a) an NIH Biosketch for the principal investigator, and (b) a detailed budget with a breakdown of costs into personnel, suppl...
Source: ScanGrants feed - July 16, 2014 Category: Research Authors: Migraine Research Foundation Source Type: funding

Request for Proposals: Pediatric and Adolescent Migraine
Letter of Intent due date: June 10, 2014 Specific Area of Interest for this RFP: It is our intent to support projects that focus on the design and implementation of a comprehensive learning and change strategy that facilitates improving a clinician’s understanding of the appropriate diagnosis and management of migraines in the pediatric and adolescent patient. Multi-disciplinary collaborations are encouraged when appropriate, but all partners must have a relevant role. It is expected that projects will be evidence-based (education and/or quality improvement) and the proposed research/evaluation w...
Source: ScanGrants feed - June 2, 2014 Category: Research Authors: Pfizer Source Type: funding

Neurobiology of Migraine (R21)
Funding Opportunity Number: PA-14-069 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: HealthCFDA Number: 93.12193.17393.27393.31393.853Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(...
Source: Grants.gov - January 13, 2014 Category: Research Tags: Health Source Type: funding